相关实验视频

Updated: May 29, 2025

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

揭示了铜-61与-68在SSTR PET成像中的潜力

A I Fonseca¹, J Sereno², S Almeida¹

¹ICNAS Pharma, University of Coimbra, Coimbra, Portugal.

European journal of nuclear medicine and molecular imaging

|February 5, 2025

概括

铜-61 (Cu61) 放射性药物显示出神经内分泌瘤 (NET) 成像的前景. 与-68 (Ga) 类似物相比,Cu-NOTA-TATE提供了优越的晚期成像,提高了NET检测.

科学领域:

核医学就是核医学.
放射化学放射化学是指辐射化学.
在瘤学瘤学.

背景情况:

铜-61 (Cu61) 是一个有前途的放射性同位素,可用于正子发射断层扫描 (PET) 成像,因为它具有有利的衰变特性和易于生产.
神经内分泌瘤 (NETs) 经常使用标有-68 (Ga) 的体静止素受体 (SST) 类似物进行成像.

研究的目的:

评估基于Cu的61型放射性药物作为68Ga的替代品,用于NET的PET成像.
为了比较61标记Cu的SST类型的性能与68的Ga类型的SST类型.

主要方法:

是通过对天然液体目标进行辐射而产生的.
在体外研究中使用SSTR阳性AR42J瘤细胞来评估Cu-和Ga-标记的SST类似物.
在体内评估涉及携带AR42J皮下瘤的小鼠的PET/MRI.

主要成果:

对于[⁶¹Cu]Cu-DOTA-TATE和[⁶¹Cu]Cu-NOTA-TATE,获得了高 activity和稳定性 (>95%放射性化学纯度≥6小时).
[⁶¹Cu]Cu-NOTA-TATE证明了高瘤吸收率 (13.25 ± 1.86%ID/g在下午1小时) 并随着时间的推移改善了瘤与非瘤的比率.
临床前的PET/MR成像显示[⁶¹Cu]Cu-NOTA-TATE的生物分布和成像特性优于[⁶¹Cu]Cu-DOTA-TATE和[⁶⁸Ga]同类物,具有延长的成像窗口.

结论:

[⁶¹Cu]Cu-NOTA-TATE的早期生物分布与[⁶⁸Ga]Ga-DOTA-TATE相似,但具有优越的晚期成像特性.
这些发现凸显了[⁶¹Cu]Cu-NOTA-TATE在增强的NET检测和改进的翻译价值方面的潜力.

关键词:

铜-61 铜-61 铜-61 铜这就是DOTA-TATE.网络网络网络网络备忘录 - 备忘录的时间.在这里,PET是PET.

更多相关视频

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...